Alessandra Bearz, MD, CRO National Cancer Institute, Aviano, Italy, describes current unmet needs for oncogene addicted patients with NSCLC and brain metastases, including elucidating the most effective therapies for first-line treatment as well as strategies to overcome resistance. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.
